INCORPORATING INJECTABLE PREP AND NEWER FORMULATIONS INTO LMIC
Dr. Pillay will discuss perspectives about the rationale and considerations for long-acting PrEP as an additional HIV prevention tool for low and middle income countries, in addition to anticipating and preparing for implementation issues.